drugset / Trial / NCT05979896
Chemoprevention Efficacy Study Nigeria
NaSingle-groupOpen-labelPrevention
Summary
The study aims to assess the chemoprevention efficacy of Sulfadoxine-Pyrimethamine and Amodiaquine (SPAQ) used in standard age-based dosing regimens used in Seasonal Malaria Chemoprevention (SMC) and SPAQ resistance marker prevalences and assocations among children 3 - 59 months in Sokoto and Kwara States, Nigeria.
Timeline
- Start
- 2023-07-28
- Primary completion
- 2023-09-15
- Completion
- 2024-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | amodiaquine | Other / unclassified | — | — |
| Subject | pyrimethamine | Small molecule | — | Oral |
| Subject | sulfadoxine | Small molecule | — | Oral |